Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Abstract Session

Rheumatoid arthritis (RA)
General Topic: Clinical Science

14T176: Abstracts: RA – Treatments III: Predictors of Response & Tapering (2539–2544)

Tuesday, November 14, 2023
4:00 PM - 5:30 PM PT
Location: Ballroom 20B-C

On Demand In Person

    Presenting Author(s)

  • Joshua Baker, MD, MS

    University of Pennsylvania
    Philadelphia, PA, United States

    Disclosure(s): CorEvitas: Consultant (Ongoing); Cumberland Pharma: Consultant (Terminated)

  • Siri Lillegraven, MD, PhD, MPH

    Diakonhjemmet Hospital
    Oslo, Norway

    Disclosure(s): Boehringer-Ingelheim: Grant/Research Support (Ongoing)

  • JL

    Jinqi LIU, PhD

    Bristol Myers Squibb
    Princeton, NJ, United States

    Disclosure information not submitted.

  • DO

    Diego Orellana, BA

    University of California, Santa Barbara
    San Francisco, CA, United States

    Disclosure information not submitted.

  • JP

    Jun Won Park, MD

    Seoul National University Hospital
    Seoul, South Korea

    Disclosure information not submitted.

  • IS

    Ismael Sanchez-Pareja

    IMIBIC/Reina Sofia Hospital/University of Cordoba
    Córdoba, Spain

    Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

  • 4:00 PM - 4:10 PM PT
    Baseline IL-10 Levels as a Predictive Biomarker for Achieving Clinical Response with Abatacept in ACPA+ Patients with Early RA

    Presenting Author: Jinqi LIU, PhD – Bristol Myers Squibb

  • 4:10 PM - 4:15 PM PT
    Q&A
  • 4:15 PM - 4:25 PM PT
    The Molecular Stratification of Rheumatoid Arthritis Using High-throughput Technologies Is Directly Associated with Disease Activity and Clinical Response

    Presenting Author: Ismael Sanchez-Pareja – IMIBIC/Reina Sofia Hospital/University of Cordoba

  • 4:25 PM - 4:30 PM PT
    Q&A
  • 4:30 PM - 4:40 PM PT
    Differential Responses to Initial Treatment Strategies for Rheumatoid Arthritis Among Those with Lower Body Mass and Adiposity

    Presenting Author: Joshua F. Baker, MD, MS – University of Pennsylvania

  • 4:40 PM - 4:45 PM PT
    Q&A
  • 4:45 PM - 4:55 PM PT
    Impact of Concomitant Methotrexate on Disease Activity After Tapering Abatacept in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study

    Presenting Author: Jun Won Park, MD – Seoul National University Hospital

  • 4:55 PM - 5:00 PM PT
    Q&A
  • 5:00 PM - 5:10 PM PT
    Clinical and Radiographic Results of Tapering and Withdrawing CsDMARDs versus Stable Treatment in Patients with Rheumatoid Arthritis in Remission: 3-year Results from a Randomized Controlled Trial

    Presenting Author: Siri Lillegraven, MD, PhD, MPH – Diakonhjemmet Hospital

  • 5:10 PM - 5:15 PM PT
    Q&A
  • 5:15 PM - 5:25 PM PT
    Microbial Metabolism of Methotrexate Contributes to Its Pharmacokinetics in Vivo

    Presenting Author: Diego Orellana, BA – University of California, Santa Barbara

  • 5:25 PM - 5:30 PM PT
    Q&A